These innovative therapies , Semaglutide , represent a groundbreaking advancement in treating type 2 diabetes and potentially associated conditions . They all are categorized as GLP-1 hormone agonists , https://gregoryxuwy600906.creacionblog.com/41281635/semaglutide-a-deep-examination-into-incretin-compounds